⌘K

Login Start Free

Home/Filings/4/0001206467-03-000001

4//SEC Filing

NABI BIOPHARMACEUTICALS 4

Accession 0001206467-03-000001

$VXRTCIK 0000072444operating

View on SEC.gov Company Profile

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 6:32 PM ET

Size

4.7 KB

Accession

0001206467-03-000001

Insider Transaction Report

Form 4

Period: 2003-05-31

NABI BIOPHARMACEUTICALSNABI

Sr. VP Fin., CFO, CAO & Treas.

Transactions

Other
Common Stock
2003-05-31$5.94/sh+1,706.64$10,140→ 14,337.077 total

Footnotes (1)

[F1]Voluntarily reported acquisition under the issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3(c).

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NABI BIOPHARMACEUTICALS

CIK 0000072444

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000072444

Filing Metadata

Form type: 4
Filed: Nov 2, 7:00 PM ET
Accepted: Nov 3, 6:32 PM ET
Size: 4.7 KB

View on SEC.gov